Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 0.61 | 1.42 |
NAV | ₹25.24 | ₹107.73 |
Fund Started | 11 Feb 2019 | 08 Apr 2008 |
Fund Size | ₹948.83 Cr | ₹68033.76 Cr |
Exit Load | - | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 0.27% | 11.48% |
3 Year | 20.42% | 21.68% |
5 Year | 23.00% | 25.86% |
1 Year
3 Year
5 Year
Equity | 99.69% | 92.49% |
Cash | 0.31% | 5.91% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Interglobe Aviation Ltd. | 4.54% |
Hindustan Aeronautics Ltd. | 3.59% |
Vedanta Ltd. | 3.55% |
Divi's Laboratories Ltd. | 3.31% |
Varun Beverages Ltd. | 3.27% |
The Indian Hotels Company Ltd. | 3.13% |
Cholamandalam Investment and Finance Company Ltd. | 2.89% |
Tata Power Company Ltd. | 2.85% |
Power Finance Corporation Ltd. | 2.73% |
Avenue Supermarts Ltd. | 2.71% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.81% |
ICICI Bank Ltd. | 8.97% |
Reliance Industries Ltd. | 6.48% |
Larsen & Toubro Ltd. | 5.83% |
Bharti Airtel Ltd. | 4.47% |
Maruti Suzuki India Ltd. | 4.25% |
Axis Bank Ltd. | 4.23% |
Ultratech Cement Ltd. | 4.10% |
Infosys Ltd. | 3.34% |
Sun Pharmaceutical Industries Ltd. | 2.91% |
Name | Anil Ghelani | Vaibhav Dusad |
Start Date | 24 Jul 2019 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks to invest in companies which are constituents of NIFTY Next 50 Index (underlying Index) in the same proportion as in the index and seeks to generate returns that are commensurate (before fees and expenses) with the performance of the underlying Index. | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 11 Feb 2019 | 08 Apr 2008 |
Description
Launch Date